Salarius Pharmaceuticals ends Ewing sarcoma trial - Investing.com
Decoy Therapeutics Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $8.36
+68% in 7d after detection
Post-detection moves
1h
—
1d
+4.9%
3d
+38%
7d
+68%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS